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RESUMEN 
Previamente hemos demostrado la sensibilidad de cultivos de Leishmania a substratos 
de transportadores ABC y hemos desarrollado una línea de parásitos resistente a este 
tipo de compuestos, [NR(Gr)]. En el presente trabajo estudiamos la influencia del 
desarrollo de resistencia a substratos de transportadores ABC en la interacción entre el 
parásito y su célula hospedera, el macrófago. Los resultados demuestran que la 
incorporación de [NR(Gr)] está incrementada en macrófagos tratados con glibenclamida 
(GLIB) y que su sensibilidad intracelular está significativamente aumentada. La 
reversión en la sensibilidad de los parásitos resistentes a la GLIB puede ser el resultado 
de una inestabilidad de la resistencia en el ámbito intracelular o de la modificación de la 
expresión de proteínas de superficie indispensables para la supervivencia del parásito en 
el medio intracelular. En su conjunto los resultados enfatizan la importancia de la 
comprensión de la modulación de la quimio-resistencia a lo largo del ciclo de vida del 
parásito. 
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Abstract 
Drug-resistant cell lines are useful for the study of the molecular basis of chemo-
resistance. Due to changes in the adenosine 5´triphosphate binding cassette (ABC) 
transporters expression, these cells express dramatical increases in drug efflux through 
their surface membrane. We have selected aLeishmania strain [NR(Gr)] resistant to 
glibenclamide (GLIB), a drug which interacts with ABC transporters and analyzed 
whether the interaction of the parasite with its host cell changes for the resistant 
parasite. The data show that NR(Gr) incorporation is significantly increased in GLIB 
treated macrophages and that the intracellular parasite sensitivity against GLIB is 
regained. This reversion in drug sensitivity may be the result of an instability of the 
resistance during the infection and propagation of the intracellular stage of the parasite 
and could be related to an alteration in the expression of surface molecules in the 
parasite which may challenge its intracellular survival. These results emphasize the fact 
that understanding of the modulation of chemo-resistance could be relevant for the 
comprehension of the transmission of drug-resistant strains during the life cycle 
of Leishmania. 





The life cycle of Leishmania sp., obligatory intracellular parasites causative of a wide 
spectrum of diseases, includes two morphologically developmental stages; the 
extracellular promastigote and the intracellular amastigote. The chemo-therapeutical 
approach is mainly directed towards the parasite intracellular stage and is based on 
drugs like sodium stibogluconate, meglumine, pentamidine and amphotericin-B. Which 
physiological mechanisms impair the successful treatment of leishmaniasis and explain 
the low level of efficacy frequently reported are of interest and, as resistance of 
parasites to different drugs is recognized as one of the main problems, strains selected in 
vitro have been used as tools to dissect the molecular basis of this chemo-resistance 
(Ullman, 1995). 
The main mechanism related in Leishmania to drug resistance is the result of an 
increased expression of a P-glycoprotein (Pgp) which belongs to 
the adenosine binding cassette (ABC) transporter family (Callahan and Beverly, 1991; 
Legaré, et al 1994), is related to specific changes in membrane permeability, and should 
involve additional functional and biochemical changes. For example, amphotericin and 
pentamidine resistant Leishmania show alterations in membrane fluidity and saturated 
fatty acids levels (Mbongo, et al 1997) and in mitochondrial enzyme activities and 
lipophosphoglycan (LPG) expression (Basselin and Robert-Gero, 1998). 
Glibenclamide (GLIB), originally described as a K+ATP transport blocker, has been 
shown to interact with members of the ABC-transporter super-family such as the 
sulfonylurea receptor (SUR) (Inagaki, et al 1995), the cystic fibrosis trans-membrane 
conductance regulator (CFTR) (Schultz, et al 1996) and Pgp from different drug 
resistant cell lines (Golstein, et al 1999). As various species of Leishmania are sensitive 
to this drug (Ponte-Sucre, et al 1998), and in view of the increasing importance that 
drug resistance has in the treatment of leishmaniasis, we have experimentally selected a 
GLIB resistantLeishmania strain [NR(Gr)] and initiated the characterization of the 
molecular, biochemical and functional mechanisms responsible for this phenotype. The 
amplification of specific DNA sequences, as well as multiple biochemical and 
functional changes in enzymes such as pyruvate kinase and acid phosphatase, were 
found to be associated with GLIB resistance (Ponte-Sucre, et al 1997; García, et al 
2000). 
To further our insight into the physiological meaning and stability of GLIB resistance, 
in the present work we analyzed whether the interaction of Leishmania with its host 
cell, and its sensitivity to GLIB while inside the macrophage, are changed for NR(Gr). 
The data show that GLIB resistant Leishmania are efficiently incorporated by GLIB 
treated J774 macrophages, but not by naive J774 cells, and that the drug resistance 
expressed by promastigotes is not retained by the intracellular parasites. 
  
Materials and methods 
Glibenclamide was purchased from Research Biochemical International and prepared as 
described (Ponte-Sucre, et al 1998). Leishmania (L.) major (MHOM/IL/81/FE/BNI) 
was cultured as described by Solbach, et al (1986). The origin and culture of the GLIB 
sensitive Leishmania NR(Gs) is described elsewhere (Ponte-Sucre, et al 1997). The 
resistant strain, NR(Gr), was selected in vitro by successive replications of NR(Gs) 
under continuous drug pressure as described by Ponte-Sucre, et al (1997). The cell line 
J774 was grown as described (Ponte-Sucre, et al 1998). 
J774 (2 x 105 cells ml-1) were pre-incubated for 36 h, in a final volume of 0.5 ml of 
RPMI 1640 culture medium supplemented with 2 x 10-3 M L-glutamine, 20 µg ml-1 
gentamicin, 2 x 10-5 M 2-mercaptoethanol and 10% fetal bovine serum, alone or in the 
presence of 3 x 10-6 M GLIB or 20 U ml-1IFN-g. Immediately thereafter, the 
macrophages were infected in the absence of drugs for 4 h with stationary phase 
promastigotes of L. major, NR(Gs) or NR(Gr) at a parasite to macrophage ratio of 5 to 
1. After removal of extracellular parasites by thorough rinsing with fresh RPMI, the 
wells were incubated further for 24 h in the absence of drugs or in the presence of 3 x 
10-6 M GLIB or 20 U ml-1 IFN-. In order to evaluate the percentage of infected cells 
and the average number of parasites per 100 macrophages, intracellular parasites were 
quantified either at the end of the 4 h infection or the 24 h incubation by staining with 
acridine orange and ethidium bromide (Ponte-Sucre, et al 1998) and analyzed by 
fluorescence microscopy at 495 nm. 
The macrophages (1.25 x 106 cells ml-1), seeded in flat-bottom microtiter wells, were 
pre-treated, infected and further treated with or with out the drugs for 24 and 48 h using 
the protocol described in the previous section. The concentration of nitrite (NO2-) 
released by the macrophages was determined by adding 100 µl of the culture 
supernatant to 100 µl of Griess reagent (1% sulfanylamide, 0.1% naphtylethylene 
diamide dihydrochloride, 2.5% phosphoric acid) for 10 min at room temperature 
(Granger, et al 1996). The absorbance of the reaction product at 540 nm was measured 
in an ELISA reader. The NO2- concentration was determined using sodium nitrite as a 
standard. 
The percentage of infection is expressed as mean values + SEM of three experiments 
where at least 500 macrophages were analyzed. An infection index was calculated as 
{[percentage of infection (number of parasites/100 infected cells)]/1000}. Differences 
between the percentage of infection of untreated and treated macrophages were tested 
for statistical significance by the minimum 2 method (Schefler 1981a).Differences in 
infection index and NO2- concentration of untreated and treated macrophages were 
tested for statistical significance by the unpaired Student t test (Schefler 1981b). 
  
Results 
To determine whether the uptake of Leishmania by macrophages changes when GLIB 
resistant parasites are used, untreated, and IFN-g and GLIB treated macrophages were 
infected for 4 h in the absence of drugs. Untreated macrophages, showed a similar 
percentage of infection of 17% either by NR(Gs) or L. major but showed a 30% 
decrease (p<0.05) when naive macrophages were infected with NR(Gr) (Figure 1). The 
incorporation of parasites into macrophages was always stimulated by pre-treatment 
with IFN-g, pre-treatment of macrophages with GLIB decreased the percentage of 
infection with L. major and NR(Gs) 35 and 20% respectively and enhanced 
significantly the incorporation of NR(Gr) into macrophages (p<0.05 for all changes) 
(Figure 1). 
When the macrophage/parasite cultures were incubated for 24 h without drugs, the 
infection index increased 100% (p<0.05) for L. major and 35% (p<0.05) for NR(Gs) 
and did not changed significantly for NR(Gr). When already infected macrophages were 
further treated with GLIB for 24 h, the infection index decreased 70% for L. major and 
40% for NR(Gs) and, contrary to what we expected, decreased 35% for NR(Gr) (p<0.05 
for all changes) (Figure 2). 
To asses whether the clearance of sensitive and resistant strains could be explained by 
an enhanced microbicidal mechanism, we evaluated the NO formation in infected 
macrophages after the treatment with the drugs. The release of nitrite detected at 24 h in 
macrophages infected either with NR(Gs) or NR(Gr) was similar to the levels released 
by non-infected macrophages (Figure 3, continuous line). This finding suggest that 
differences in the triggering of this microbicidal mechanism cannot explain the 
clearance of NR(Gs) and NR(Gr) by macrophages. Only after a 48 h drug treatment 
with IFN-  were we able to observe an increase in the nitrite concentration. 
Figure 1: Percentage of infection by L. major, NR(Gs) and NR(Gr) of macrophages untreated or 
treated prior to the infection for 36 h with 3 M GLIB or 20 U ml–1 IFN- . *p<0.05. 
 Figure 2: Infection index of macrophages untreated or treated post infection for 24 h with 3 M 
GLIB or 20 U ml–1 IFN- . *p<0.05. 
 
Figure 3: NO production by L. major NR(Gs) and NR(Gr) infected macrophages untreated or 
treated post infection for 24 h or 48 h with 3 M GLIB or 20 U ml–1 IFN- . 
   
Discussion 
The treatment, prevention and control of leishmaniasis is more difficult everyday, not 
only because of the extreme low efficacy and high toxicity of the drugs currently in use, 
but because of the everyday increase in drug resistance among the strains that affect 
humans and other mammals. In the present study we investigated whether drug-
resistance of parasites to ABC-transporter substrates modulates the interaction 
of Leishmania with its host cell, as well as its drug sensitivity while in the macrophage. 
We have found that NR(Gr) is less infective to naive macrophages than NR(Gs). This 
result suggest that physiological changes developed during the adquisition of GLIB 
resistance could be affecting the parasite-host cell interaction and therefore the selective 
incorporation of the parasites into the macrophages. In fact, in a previous paper we had 
demonstrated that the activity of a housekeeping enzyme, pyruvate kinase, and of the 
virulence marker, acid phosphatase, are significantly decreased in the resistant strain 
(García, et al 2000). Nevertheless, pre-treatment of the macrophages with GLIB 
increased their resistance to infection with L. major, as we have previously shown 
(Ponte-Sucre, et al submitted) and NR(Gs), but not with NR(Gr), a result at present very 
difficult to explain. 
Contrary to what we expected, the infection index of macrophages loaded with NR(Gr) 
ad left untreated for 24 h did not increased and furthermore, the clearance of the 
parasites decreased 40% for NR(Gs) and 35% for NR(Gr) in GLIB treated macrophages 
(p<0.05) (Figure 2) without a significant increase in nitrite release (Figure 3). These 
results support the idea that the mechanisms involved in the maintenance of GLIB 
resistance could interfere per se with the amastigote survival and proliferation and that 
once intracellular, resistant parasites express, again, sensitivity against GLIB. A similar 
result, i.e., the intracellular dissapearance of chemo-resistance, has been observed in 
some drug selected pentamidine resistant parasites (Sereno and Lemesre, 1997). 
Alternatively, if drug resistance emergence is linked to a dys-regulation in ion exchange 
through the membrane, as has been suggested by Roepe and Martiney (1999) and 
references therein, raising a cell line resistant against an ABC-transport blocker, would 
have strong effects on pH gradients, cell volume homeostasis and cell membrane 
potential and therefore, could challenge the survival of the drug selected parasite inside 
the acidic phagolysosomal compartment of the macrophage. In this line of evidences, 
preliminary results from our laboratory suggest that intracellular resistant but not 
sensitive parasites are extremely sensitive to amiloride, a Na+/H+ exchanger blocker. 
Altogether, these results emphasize the multiple functional changes which may arise 
from the phenomena of drug resistance and the attention that should be given to 
understand the biochemical and functional mechanisms involved, as well as the 
relevance of the transmission of drug resistance during the life cycle of the parasite. 
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